Arid1a is a signature subunit of the mammalian SWI/SNF ATPdependent chromatin remodeling complex. We performed an ENU mutagenesis screen for Arid1a coding mutations and generated mice carrying a valine-to-glycine point mutation in the ARID DNA binding domain of Arid1a. Although mutant protein is expressed near wildtype levels and capable of interacting with its catalytic subunit, Brg1, it appears to display reduced DNA binding capacities in vitro. Homozygous mutant embryos undergo development arrest by E10.5 and exhibit defects in the trophoblast placenta and extraembryonic vasculature, including a compacted labyrinth layer and reduced vascular branching. These data suggest the ARID domain of Arid1a is essential for development.
The transcription factor GATA-1 and its cofactor Friend of GATA (FOG) are required to promote embryonic red blood cell (RBC) development in mice. In contrast, the current model in Xenopus, based on overexpression studies, predicts that FOG inhibits RBC development by recruiting the transcriptional co-repressor Cterminal Binding Protein (CtBP). To resolve these seemingly contradictory findings, we have used morpholinos to perform a loss-offunction study in frogs. We find that in Xenopus, as in mice, FOG is in fact required for RBC development. Specifically, targeted injection of FOG morpholinos into the ventral blood-forming mesoderm of 8-cell Xenopus embryos results in a dose-dependent loss of globin expression at the tailbud stage. In addition, we find that overexpression of both wildtype FOG and mutant FOG isoforms that either lack known repressor binding domains, or harbor mutations at key GATA-interaction residues, also result in loss of blood. Together, these studies suggest that FOG is required for RBC development and that loss of blood seen with FOG overexpression is likely due to a dominant-interfering effect by which excess FOG sequesters other co-factors required for RBC development away from endogenous target promoters. The Cdx genes encode homeodomain transcription factors related to caudal in Drosophila. The three mouse homologues, Cdx1, Cdx2 and Cdx4, are essential for proper vertebral anterior-posterior patterning in all vertebrate model systems examined to date. Cdx1 and Cdx2 (but not Cdx4) are also expressed in the intestinal epithelium during development and expression persists throughout the lifespan of the mouse. Cdx1 null mice exhibit homeotic transformations of the axial skeleton, but no phenotype of the intestine has been described. Cdx2 null mice die at embryonic day 3.5 (E3.5) due to a failure of implantation and preventing assessment of the null phenotype at later stages. Cdx2 heterozygous mice display vertebral homeoses and occasional polyps in the colon and small intestine. Areas of metaplasia within these lesions exhibit an esophageal-like keratinized epithelium, suggestive of a transformation of the intestinal epithelium to a more anterior (stomach) character, and supporting a critical role for Cdx2 in the patterning of the intestinal endoderm. To more fully address the role of Cdx2 in the intestine, we are using a tamoxifen-inducible villin-Cre transgenic, which is expressed in the definitive intestinal endoderm commencing at E9.5 to inactivate a floxed Cdx2 allele, thus circumventing the early lethality inherent to Cdx2 null embryos. Results from this conditional mutant are consistent with a role for Cdx2 in patterning the small intestine. Limited knowledge of the molecular mechanisms that regulate endocrine b-cell differentiation in the pancreas of has thus far precluded the development of a viable, cell-based therapy for diabetes mellitus. A key unanswered question is how multipotential pancreatic progenitors become specified to adopt an endocrine or an exocrine fate. By combining genetic lineage tracing, loss of function, and misexpression experiments in mice, we demonstrate that reciprocal repression between the transcription factors Nkx6.1 and Ptf1a patterns the undifferentiated pancreatic progenitor epithelium into a pre-endocrine and pre-exocrine domain. Our data shows that Nkx6.1 establishes a preendocrine domain by directly repressing the exocrine fate determinant Ptf1a. Compared to wild type embryos, Nkx6.1 mutants display an expansion of the pre-exocrine domain, as marked by Ptf1a, as well as a loss of endocrine cells. Furthermore, constitutive and heritable expression of Nkx6.1 in multipotential progenitors is sufficient to block exocrine differentiation and directs progenitors into an endocrine fate. Conversely, misexpression of Ptf1a in pancreatic progenitors suppresses Nkx6.1 expression and prevents endocrine cell differentiation. Overall, these results suggest that pancreatic endocrine and exocrine cell fate are established in undifferentiated, multipotential progenitors by a crossinhibitory loop between Nkx6.1 and Ptf1a.
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